{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:27:30Z","timestamp":1791329250927,"version":"4.3.1"},"reference-count":164,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.critrevonc.2008.06.003","type":"journal-article","created":{"date-parts":[[2008,7,25]],"date-time":"2008-07-25T08:59:35Z","timestamp":1216976375000},"page":"28-44","source":"Crossref","is-referenced-by-count":87,"title":["Hereditary ovarian cancer"],"prefix":"10.1016","volume":"69","author":[{"given":"Antonio","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetana","family":"Di Fede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.06.003_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bpobgyn.2005.10.016","article-title":"Prevention of ovarian cancer","volume":"20","author":"Hanna","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5","article-title":"A prospective study of reproductive factors and risk of epithelial ovarian cancer","volume":"76","author":"Hankinson","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.2910640608","article-title":"Risk modifiers in carriers of BRCA1 mutations","volume":"64","author":"Narod","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9378(98)70372-2","article-title":"Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study","volume":"179","author":"Godard","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.1998.tb10148.x","article-title":"A systematic review and meta-analysis of family history and risk of ovarian cancer","volume":"105","author":"Stratton","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00004347-200101000-00005","article-title":"Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features","volume":"20","author":"Werness","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.1996.352","article-title":"Cancer incidence in the first-degree relatives of ovarian cancer patients","volume":"74","author":"Auranen","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib8","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib9","series-title":"The genetic basis of human cancer","first-page":"537","article-title":"Breast Cancer","author":"Couch","year":"1998"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib10","first-page":"889","article-title":"Risk of breast and ovarian cancer in women with strong family histories","volume":"15","author":"Srivastava","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.318.7186.786","article-title":"Forth nightly review: hereditary ovarian carcinoma","volume":"318","author":"Kasprzak","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng1107","article-title":"The genetics and genomics of cancer","volume":"33 Suppl.","author":"Balmain","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/386761a0","article-title":"Cancer-susceptibility genes. Gatekeepers and caretakers","volume":"386","author":"Kinzler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0090-8258(90)90107-V","article-title":"Hereditary carcinoma of the ovary and associated cancers: a study of two families","volume":"36","author":"Lynch","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib16","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1006\/gyno.2002.6674","article-title":"Specific keynote: hereditary ovarian cancer: what we know","volume":"88","author":"Boyd","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.117.2.206","article-title":"Hereditary factors in cancer. Study of two large midwestern kindreds","volume":"117","author":"Lynch","year":"1966","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.c.30026","article-title":"Inherited predisposition to cancer: a historical overview","volume":"129","author":"Lynch","year":"2004","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-128-11-199806010-00004","article-title":"Increased risk for cancer in patients with the Peutz-Jeghers syndrome","volume":"128","author":"Boardman","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0733-8635(18)30114-1","article-title":"Nevoid basal cell carcinoma syndrome","volume":"13","author":"Gorlin","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0596-114","article-title":"Localization of the gene for Cowden disease to chromosome 10q22-23","volume":"13","author":"Nelen","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/beog.2002.0296","article-title":"The genetics of ovarian cancer","volume":"16","author":"Pharoah","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib24","first-page":"678","article-title":"Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium","volume":"52","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","article-title":"Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation","volume":"11","author":"Gayther","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-006-9456-9","article-title":"BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses","volume":"105","author":"Russo","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib31","first-page":"147","article-title":"BRCA1, BRCA2 and breast cancer: a concise clinical review","volume":"24","author":"Carter","year":"2001","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1521-1878(200008)22:8<728::AID-BIES6>3.0.CO;2-B","article-title":"Roles of BRCA1 and its interacting proteins","volume":"22","author":"Deng","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/bcr76","article-title":"Role of BRCA gene dysfunction in breast and ovarian cancer predisposition","volume":"2","author":"Scully","year":"2000","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-007-9499-6","article-title":"Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and\/or ovarian cancer families","volume":"106","author":"Buffone","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib36","article-title":"BRCA1\/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases","author":"Falchetti","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib37","doi-asserted-by":"crossref","first-page":"vi86","DOI":"10.1093\/annonc\/mdm233","article-title":"High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability","volume":"18 Suppl. 6","author":"Veschi","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/humu.20169","article-title":"Genomic rearrangements in the BRCA1 and BRCA2 genes","volume":"25","author":"Mazoyer","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes","volume":"86","author":"Antoniou","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/humu.20599","article-title":"Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer","volume":"28","author":"Ramus","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib41","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","article-title":"Epidemiology of male breast cancer","volume":"14","author":"Weiss","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib43","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/carcin\/bgi136","article-title":"BRCA1 and BRCA2 as ovarian cancer susceptibility genes","volume":"26","author":"Sowter","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib47","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/jnci\/djg072","article-title":"Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia","volume":"95","author":"Offit","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib48","doi-asserted-by":"crossref","first-page":"vi93","DOI":"10.1093\/annonc\/mdm234","article-title":"Founder mutations in BRCA1 and BRCA2 genes","volume":"18 Suppl. 6","author":"Ferla","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/jmg.2004.024133","article-title":"Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies","volume":"42","author":"Antoniou","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib50","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib51","first-page":"1284","article-title":"Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families","volume":"57","author":"Friedman","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","article-title":"A review of the diagnosis and management of male breast cancer","volume":"10","author":"Giordano","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10689-004-9552-0","article-title":"Hereditary ovarian cancer in Ashkenazi Jews","volume":"3","author":"Robles-Diaz","year":"2004","journal-title":"Fam Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10689-004-9550-2","article-title":"Hereditary breast cancer in Jews","volume":"3","author":"Rubinstein","year":"2004","journal-title":"Fam Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib57","first-page":"3776","article-title":"Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations","volume":"8","author":"Satagopan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1095-198","article-title":"The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals","volume":"11","author":"Struewing","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0959-8049(99)00050-7","article-title":"Three percent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA","volume":"35","author":"Dorum","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","article-title":"A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes","volume":"13","author":"Thorlacius","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib61","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1471-7697(03)00066-2","article-title":"Genetics of ovarian cancer","volume":"4","author":"Pandit","year":"2004","journal-title":"Rev Gynaecol Pract"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1054\/cuog.2001.0232","article-title":"Family history of ovarian cancer","volume":"12","author":"Cook","year":"2002","journal-title":"Curr Obstet Gynaecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib67","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1525-1438.2003.13194.x","article-title":"The contribution of DNA mismatch repair gene defects to the burden of gynecological cancer","volume":"13","author":"Drake","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib68","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.2003.04.060","article-title":"Role of DNA mismatch repair defects in the pathogenesis of human cancer","volume":"21","author":"Peltomaki","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gut.47.1.148","article-title":"DNA mismatch repair genes and colorectal cancer","volume":"47","author":"Wheeler","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib70","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/carcin\/17.9.1799","article-title":"Microsatellite instability differences between familial and sporadic ovarian cancers","volume":"17","author":"Arzimanoglou","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib71","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.genet.33.1.533","article-title":"Mammalian DNA mismatch repair","volume":"33","author":"Buermeyer","year":"1999","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(03)00287-7","article-title":"Mechanisms of human DNA repair: an update","volume":"193","author":"Christmann","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib73","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","article-title":"Microsatellite instability in cancer of the proximal colon","volume":"260","author":"Thibodeau","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib74","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/gyno.2000.6065","article-title":"Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance","volume":"80","author":"Brown","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000057986","article-title":"Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals","volume":"53","author":"Zaykin","year":"2002","journal-title":"Hum Hered"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib76","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/carcin\/bgl089","article-title":"Common variants in mismatch repair genes and risk of invasive ovarian cancer","volume":"27","author":"Song","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib77","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ijc.2910640614","article-title":"Genetic alterations distinguish different types of ovarian tumors","volume":"64","author":"Pieretti","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib78","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02053699","article-title":"The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)","volume":"34","author":"Vasen","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3322\/canjclin.56.4.213","article-title":"Diagnostic approach and management of lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians","volume":"56","author":"Hendriks","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib80","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","article-title":"A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines","volume":"89","author":"Rodriguez-Bigas","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib81","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9440(10)63841-2","article-title":"Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors","volume":"162","author":"Hendriks","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib82","first-page":"5849","article-title":"Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history","volume":"53","author":"Lothe","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib83","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/hmg\/5.9.1245","article-title":"Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer","volume":"5","author":"Moslein","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib84","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.20.4.1043","article-title":"Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors","volume":"20","author":"Lindor","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib85","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/gyno.1994.1065","article-title":"The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer","volume":"52","author":"Bourne","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib86","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jama.273.7.577","article-title":"Assessment and counseling for women with a family history of breast cancer: a guide for clinicians","volume":"273","author":"Hoskins","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib87","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1023\/A:1011176107455","article-title":"Cancer genetics in oncology practice","volume":"12","author":"Olopade","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib88","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1037\/0278-6133.21.6.564","article-title":"A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire","volume":"21","author":"Cella","year":"2002","journal-title":"Health Psychol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jmwh.2004.01.021","article-title":"Genetic testing for breast and ovarian cancer susceptibility: a family experience","volume":"49","author":"Van Riper","year":"2004","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib90","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib91","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","article-title":"Application of breast cancer risk prediction models in clinical practice","volume":"21","author":"Domchek","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib92","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib94","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.278.15.1242","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib95","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/annonc\/mdh183","article-title":"An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer","volume":"15","author":"Contegiacomo","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib96","doi-asserted-by":"crossref","first-page":"iv133","DOI":"10.1093\/annonc\/mdh917","article-title":"Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics","volume":"15 Suppl. 4","author":"Eccles","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.9-1-13","article-title":"Recognition and management of hereditary breast cancer syndromes","volume":"9","author":"Thull","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib98","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mrfmmm.2004.07.024","article-title":"Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1","volume":"573","author":"Judkins","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib99","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.2001.6465","article-title":"Hereditary ovarian cancer. Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry","volume":"85","author":"Piver","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib101","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib102","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-005-0696-7","article-title":"Hereditary breast and ovarian cancer: review and future perspectives","volume":"84","author":"Lux","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib103","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib104","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.20.2.463","article-title":"Effect of BRCA mutations on the length of survival in epithelial ovarian tumors","volume":"20","author":"Ben David","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib105","first-page":"235","article-title":"Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1","volume":"4","author":"Aida","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib106","first-page":"1196","article-title":"Failure of BRCA1 dysfunction to alter ovarian cancer survival","volume":"8","author":"Buller","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib107","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden","volume":"16","author":"Johannsson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib108","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4161\/cc.5.9.2726","article-title":"BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance","volume":"5","author":"Chabalier","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib109","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.10667","article-title":"Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer","volume":"102","author":"Boks","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0301-2115(98)00219-X","article-title":"Is there a place for screening in ovarian cancer?","volume":"82","author":"MacDonald","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","article-title":"CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer","volume":"100","author":"Olivier","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00006254-198406000-00001","article-title":"Detection of malignant ovarian neoplasms: a review of the literature. I. Detection of the patient at risk; clinical, radiological and cytological detection","volume":"39","author":"Smith","year":"1984","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib113","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0959-8049(96)00137-2","article-title":"Early detection of familial ovarian cancer","volume":"32A","author":"Dorum","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib114","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/1097-0142(19951115)76:10+<2011::AID-CNCR2820761318>3.0.CO;2-L","article-title":"Ovarian cancer screening. The role of ultrasound in early detection","volume":"76","author":"Karlan","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/1097-0142(19910801)68:3<458::AID-CNCR2820680303>3.0.CO;2-3","article-title":"Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography","volume":"68","author":"Van Nagell","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib116","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9378(96)70380-0","article-title":"Early detection of ovarian carcinoma with transvaginal color Doppler ultrasonography","volume":"174","author":"Fleischer","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib117","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7863\/jum.1993.12.7.387","article-title":"Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging","volume":"12","author":"Weiner","year":"1993","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib118","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/bmj.306.6884.1025","article-title":"Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging","volume":"306","author":"Bourne","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib119","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0090-8258(91)90051-6","article-title":"Ultrasound screening for familial ovarian cancer","volume":"43","author":"Bourne","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib120","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","article-title":"Screening for ovarian cancer: a pilot randomised controlled trial","volume":"353","author":"Jacobs","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib121","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1200\/JCO.2004.07.179","article-title":"Biology of epithelial ovarian cancer: implications for screening women at high genetic risk","volume":"22","author":"Hogg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib122","doi-asserted-by":"crossref","unstructured":"The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med 1987;316:650\u20135.","DOI":"10.1056\/NEJM198703123161102"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib123","first-page":"708","article-title":"A quantitative assessment of oral contraceptive use and risk of ovarian cancer","volume":"80","author":"Hankinson","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib124","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cncr.2820710214","article-title":"Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981\u20131991","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib127","first-page":"3678","article-title":"Does oral contraceptive use increase the risk of breast cancer in women with BRCA1\/BRCA2 mutations more than in other women?","volume":"57","author":"Ursin","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib128","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib129","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(02)11087-7","article-title":"BRCA1: mechanisms of inactivation and implications for management of patients","volume":"360","author":"Kennedy","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib131","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","article-title":"Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib132","first-page":"33","article-title":"Prophylactic oophorectomy in inherited breast\/ovarian cancer families","author":"Struewing","year":"1995","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib133","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families","volume":"2","author":"Tobacman","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib134","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib135","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib136","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/beog.2002.9305","article-title":"Prophylactic oophorectomy","volume":"16","author":"Coukos","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib137","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198704303161801","article-title":"Menopause and the risk of coronary heart disease in women","volume":"316","author":"Colditz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib138","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.2.5862.325","article-title":"Osteoporosis after oophorectomy for non-malignant disease in premenopausal women","volume":"2","author":"Aitken","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib139","unstructured":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350:1047\u201359."},{"key":"10.1016\/j.critrevonc.2008.06.003_bib140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.273.6.491","article-title":"Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer","volume":"273","author":"NIH consensus conference","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib141","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.277.12.997","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib142","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1998.16.3.979","article-title":"Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients","volume":"16","author":"Grann","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib143","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM199705153362022","article-title":"Decision analysis\u2014effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations","volume":"336","author":"Schrag","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib144","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/jco.2002.08.035","article-title":"Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy","volume":"20","author":"van Roosmalen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib145","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib146","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib147","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib148","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib149","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib150","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib151","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","article-title":"Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation","volume":"355","author":"Meijers-Heijboer","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib152","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1054\/bjoc.1999.1086","article-title":"Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group","volume":"82","author":"Wagner","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib153","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1006\/pmed.2001.0924","article-title":"Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer?","volume":"33","author":"Fry","year":"2001","journal-title":"Prev Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib154","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/1099-1611(200011\/12)9:6<496::AID-PON487>3.3.CO;2-Q","article-title":"Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer","volume":"9","author":"Meiser","year":"2000","journal-title":"Psychooncology"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00003081-200109000-00002","article-title":"Hereditary cancers in obstetrics and gynecology","volume":"44","author":"Swisher","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib156","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib157","first-page":"297","article-title":"Issues surrounding surgical menopause. Indications and procedures","volume":"46","author":"Reich","year":"2001","journal-title":"J Reprod Med"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib158","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib159","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1001\/jama.270.23.2813","article-title":"Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study","volume":"270","author":"Hankinson","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib160","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib161","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0020-7292(92)90655-3","article-title":"The role of prophylactic oophorectomy in the avoidance of ovarian cancer","volume":"39","author":"Schwartz","year":"1992","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib162","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0029-7844(99)00452-4","article-title":"Factors affecting prophylactic oophorectomy in postmenopausal women","volume":"94","author":"Gross","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib163","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1634\/theoncologist.1-5-326","article-title":"Prophylactic oophorectomy: reducing the U.S. death rate from epithelial ovarian cancer. A continuing debate","volume":"1","author":"Piver","year":"1996","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2008.06.003_bib164","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.52.1.8","article-title":"American Cancer Society guidelines for the early detection of cancer","volume":"52","author":"Smith","year":"2002","journal-title":"CA Cancer J Clin"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T09:50:45Z","timestamp":1684489845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1040842808001169"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.06.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}